Unknown

Dataset Information

0

Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.


ABSTRACT: Even though cancer treatment has improved over the recent decades, still more specific and effective treatment concepts are mandatory. Surgical removal is not always possible, metastases are challenging and chemo- and radiotherapy can not only have severe side-effects but also resistances may occur. To cope with these challenges more efficient therapies with fewer side-effects are required. One promising approach is the use of drug delivery vehicles. Here, mesoporous silica nanoparticles (MSN) are discussed as biodegradable drug carrier to improve efficacy and reduce side-effects. MSN excellently fulfill the criteria for nanoparticulate carriers: their distinct structure allows high loading capacity and a plethora of surface modifications. MSN synthesis permits fine-tuning of particle and pore sizes. Moreover, drug release can be tailored through various gatekeeper systems which are for example pH-sensitive or redox-sensitive. Furthermore, MSN can either enter tumors passively by the enhanced permeability and retention effect or can be actively targeted by various ligands. PEGylation prolongs circulation time and availability. A huge advantage of MSN is their explicitly low toxic profile in vivo. Yet, clinical translation remains challenging. Overall, mesoporous silica nanoparticles are a promising tool for innovative, more efficient and safer cancer therapies.

SUBMITTER: Watermann A 

PROVIDER: S-EPMC5535255 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.

Watermann Anna A   Brieger Juergen J  

Nanomaterials (Basel, Switzerland) 20170722 7


Even though cancer treatment has improved over the recent decades, still more specific and effective treatment concepts are mandatory. Surgical removal is not always possible, metastases are challenging and chemo- and radiotherapy can not only have severe side-effects but also resistances may occur. To cope with these challenges more efficient therapies with fewer side-effects are required. One promising approach is the use of drug delivery vehicles. Here, mesoporous silica nanoparticles (MSN) a  ...[more]

Similar Datasets

2023-12-04 | GSE247020 | GEO
| S-EPMC6008237 | biostudies-literature
| S-EPMC7215304 | biostudies-literature
| S-EPMC3776216 | biostudies-other
| S-EPMC2952648 | biostudies-other
| S-EPMC3155389 | biostudies-literature
| S-EPMC3149161 | biostudies-literature
| S-EPMC7910993 | biostudies-literature
| S-EPMC8468042 | biostudies-literature
| S-EPMC7017376 | biostudies-literature